Eight Meridian Investigators Voted ‘Best of Savannah’ by Savannah Magazine Readers
SAVANNAH, GA. (PRWEB) SEPTEMBER 19, 2018 — Seven physicians and one physician assistant that serve as principal investigators for Meridian Clinical Research have won a ‘Best of Savannah Doctors 2018’ award. The award winners were determined by reader votes and are featured in the September/October issue of Savannah Magazine.
Meridian Principal Investigator Corinne Howington, MD, Conducted Research for Acne Product That Receives FDA Clearance
Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its lead product, Sebacia Microparticles. This significant achievement is a milestone in the treatment of acne and follows the company’s completion of its pivotal study, which clearly demonstrated clinical efficacy and safety of Sebacia Microparticles, and its 510(k) submission to the FDA in June 2018. In partnership with Meridian Clinical Research, Corinne Howington, MD, led a clinical study for this product at Low Country Dermatology in Savannah, GA. Meridian congratulates Dr. Howington and her team. Read … Read more
Results From Meridian Clinical Research Studies Featured in Prestigious Publications and Academic Presentations
OMAHA, NEB., NORFOLK, NEB., AND SAVANNAH, GA. (PRWEB LINK) AUGUST 16, 2018 Results from clinical trials performed at Meridian Clinical Research sites in Norfolk, Neb., Omaha, Neb., and Savannah, Ga., were recently published in two prestigious medical journals. Dr. Brandon Essink, Meridian’s medical director and principal investigator, co-authored an article published in Vaccine. Dr. Essink led a study at Meridian’s Omaha, Neb., site as part of a successful clinical trial for a vaccine found to provide broad protection against meningococcal disease (meningitis).
Dr. Brandon Essink Co-Authors Article Published in the Journal, Vaccine
Meridian Medical Director and Principal Investigator Dr. Brandon Essink co-authored an article recently published in the prestigious journal, Vaccine. A successful meningococcal disease vaccine trial led to this publication, which you can read now at: https://lnkd.in/dGCjtRH Title: Breadth of Coverage Against a Panel of 110 Invasive Disease Isolates, Immunogenicity and Safety for 2 and 3 Doses of an Investigational MenABCWY Vaccine in US Adolescents – Results From a Randomized, Controlled, Observer-Blind Phase II Study
Meridian Clinical Research Holds Fourth Annual Physician Training Meeting
Meridian Clinical Research held its largest ever Annual Physician Training Meeting July 12-14, 2018 in Cancun, Mexico. More than 150 attended the event, including 50 principal investigators and sub-investigators. Physicians from all 18 Meridian sites attended, along with representatives from each of Platinum Research Network’s seven companies. “It provides us an opportunity to share with investigators how we are preparing for, and shaping the future of clinical research,” said Greg Adams, director clinical management at Pfizer. Adams, who spoke and fielded questions at the event, also said the meeting served as a platform to share expectations and explore ideas for … Read more
2018 Muscle Walk of Omaha to be Presented by Meridian Clinical Research
Omaha, Neb., April 18, 2018 — This year’s Muscular Dystrophy Association’s (MDA) Muscle Walk of Omaha is scheduled for May 5 at Miller’s Landing Rivers Edge State Park beginning at 9 a.m. Meridian Clinical Research is presenting sponsor and is matching every donation to the Muscle Walk up to a total of $7,500, until April 23. To register or donate, visit Meridian’s page on the MDA website. The MDA is leading the fight to free individuals — and the families who love them — from the harm of muscular dystrophy, amyotrophic lateral sclerosis (ALS), and related diseases that take away … Read more
Meridian Founder and CEO Nicole Osborn Appointed to SCRS Leadership Council
Omaha, Neb., March 27, 2018 — The Society for Clinical Research Sites (SCRS) named Nicole Osborn, founder and CEO of Meridian Clinical Research, to its Leadership Council. As an experienced and committed executive of the research industry, Osborn will provide strategic guidance, policy decisions, and oversight for SCRS. “We’re excited to welcome Nikki Osborn to our Leadership Council,” said SCRS president Christine Pierre. “Her decades of successful site management and entrepreneurship will be of tremendous value to the SCRS Leadership Council and our members.” “SCRS is a global organization that unifies the voice of the clinical research site community to create … Read more
The Dermatology Clinic in Baton Rouge, LA Partners With Meridian
From the Physicians at The Dermatology Clinic: At The Dermatology Clinic, our goal is to provide the best possible care for patients. Sometimes it’s as easy as writing a prescription or giving a shot — other times the best treatment is still in development. That is why clinical studies are so important. Without clinical studies, it would be impossible to develop new medicines and cures. Clinical studies offer more care options for our patients suffering from common, unique, and rare health conditions. This is especially helpful for patients who struggle to find effective therapies currently on the market. In short, … Read more
Meridian Helps Norfolk Connect With National RSV Study
Krystal Preister of Norfolk knows the importance of protecting a child from harmful diseases early in life, as well as the risk of delivering a baby during RSV virus season. That’s why the mother and obstetrics nurse at Faith Regional Health Services’ women’s health department didn’t hesitate to join what was known as a “respiratory syncytial virus F vaccine trial” when she learned Midwest Health Partners of Norfolk was participating in the research. Preister became involved while pregnant with her youngest son, Myles, who was born in January 2016. Preister said she believes she received the vaccine in December 2015 … Read more
Innovative Strategy to Increase Opportunity for the Traditional Research Site
MONDAY, JANUARY 25, 2016 The Pulse on Site Success by Jeffrey Adelglass The individuals responsible for management, growth and development of clinical research sites are entrepreneurs. There is definitely evidence of expanded strategic development of innovative and entrepreneurial methods to garner new revenue, patient recruitment opportunities and visibility for the traditional, free standing clinical research site. Some recent examples include the addition of a medical spa facility at the Meridian Research site in Omaha, Nebraska. Nikki Osborne, CEO of Meridian, initiated a business expansion in 2012 to allow for a potential crossover of patients taking part in spa services and interesting … Read more